Benítez-Gutiérrez L - Search Results

1

Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials.

Arias A, Aguilera A, Soriano V, Benítez-Gutiérrez L, Lledó G, Navarro D, Treviño A, Otero E, Peña JM, Cuervas-Mons V, de Mendoza C. Arias A, et al. Antivir Ther. 2017;22(4):307-312. doi: 10.3851/IMP3061. Epub 2016 Jun 24. Antivir Ther. 2017. PMID: 27341294

2

Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection.

Lledó GM, Carrasco I, Benítez-Gutiérrez LM, Arias A, Royuela A, Requena S, Cuervas-Mons V, de Mendoza C. Lledó GM, et al. Among authors: benitez gutierrez lm. AIDS. 2018 Oct 23;32(16):2347-2352. doi: 10.1097/QAD.0000000000001966. AIDS. 2018. PMID: 30096074

3

Hepatitis C cure with antiviral therapy--benefits beyond the liver.

Soriano V, Labarga P, Fernandez-Montero JV, de Mendoza C, Esposito I, Benítez-Gutiérrez L, Barreiro P. Soriano V, et al. Antivir Ther. 2016;21(1):1-8. doi: 10.3851/IMP2975. Epub 2015 Jun 25. Antivir Ther. 2016. PMID: 26110692 Review.

4

Rate and predictors of serum HCV-RNA >6 million IU/mL in patients with chronic hepatitis C.

Barreiro P, Labarga P, Fernandez-Montero JV, Mendoza Cd, Benítez-Gutiérrez L, Peña JM, Soriano V. Barreiro P, et al. J Clin Virol. 2015 Oct;71:63-6. doi: 10.1016/j.jcv.2015.08.001. Epub 2015 Aug 13. J Clin Virol. 2015. PMID: 26302484 Clinical Trial.

5

High serum HCV RNA in chronic hepatitis C patients coinfected with HIV despite successful antiretroviral therapy.

Barreiro P, Labarga P, de Mendoza C, Benítez-Gutiérrez L, Fernandez-Montero JV, Peña JM, Soriano V. Barreiro P, et al. Antivir Ther. 2016;21(6):489-494. doi: 10.3851/IMP3038. Epub 2016 Feb 18. Antivir Ther. 2016. PMID: 26887981

6

Prevention and management of treatment failure to new oral hepatitis C drugs.

Benítez-Gutiérrez L, Barreiro P, Labarga P, de Mendoza C, Fernandez-Montero JV, Arias A, Peña JM, Soriano V. Benítez-Gutiérrez L, et al. Expert Opin Pharmacother. 2016 Jun;17(9):1215-23. doi: 10.1080/14656566.2016.1182156. Epub 2016 May 9. Expert Opin Pharmacother. 2016. PMID: 27149603 Review.

7

Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C.

Esposito I, Benítez-Gutiérrez L, Treviño A, Arias A, Citores MJ, Requena S, Soriano V, Cuervas-Mons V, de Mendoza C. Esposito I, et al. Antivir Ther. 2017;22(7):571-575. doi: 10.3851/IMP3138. Epub 2017 Feb 15. Antivir Ther. 2017. PMID: 28198349

8

Treatment of hepatitis C with new fixed dose combinations.

Soriano V, Fernandez-Montero JV, de Mendoza C, Benitez-Gutierrez L, Peña JM, Arias A, Barreiro P. Soriano V, et al. Expert Opin Pharmacother. 2017 Aug;18(12):1235-1242. doi: 10.1080/14656566.2017.1346609. Epub 2017 Jul 30. Expert Opin Pharmacother. 2017. PMID: 28644739 Review.

9

Baseline NS5A resistance associated substitutions may impair DAA response in real-world hepatitis C patients.

Carrasco I, Arias A, Benítez-Gutiérrez L, Lledó G, Requena S, Cuesta M, Cuervas-Mons V, de Mendoza C. Carrasco I, et al. Among authors: benitez gutierrez l. J Med Virol. 2018 Mar;90(3):532-536. doi: 10.1002/jmv.24971. Epub 2017 Nov 3. J Med Virol. 2018. PMID: 28990680

10

Benefits of hepatitis C cure with antivirals: why test and treat?

Lledó G, Benítez-Gutiérrez L, Arias A, Requena S, Cuervas-Mons V, de Mendoza C. Lledó G, et al. Among authors: benitez gutierrez l. Future Microbiol. 2019 Mar;14:425-435. doi: 10.2217/fmb-2019-0041. Epub 2019 Mar 22. Future Microbiol. 2019. PMID: 30900911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters